09th week of 2022 patent applcation highlights part 12 |
Patent application number | Title | Published |
20220062307 | METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS | 2022-03-03 |
20220062308 | METHODS AND COMPOSITIONS FOR TREATING ROSACEA | 2022-03-03 |
20220062309 | INJECTABLE FOSAPREPITANT COMPOSITION | 2022-03-03 |
20220062310 | PSILOCYBIN IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER | 2022-03-03 |
20220062311 | A NUTRITIONAL COMPOSITION COMPRISING A COMBINATION OF HUMAN MILK OLIGOSACCHARIDES TO IMPROVE THE GASTROINTESTINAL BARRIER | 2022-03-03 |
20220062312 | ORAL COMPOSITION COMPRISING B-ESCIN AND THE USE THEREOF | 2022-03-03 |
20220062313 | SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF | 2022-03-03 |
20220062314 | NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES | 2022-03-03 |
20220062315 | ANTI-HUMAN NOROVIRUS AGENT | 2022-03-03 |
20220062316 | USE OF CANAGLIFLOZIN IN PREPARATION OF ANTITUMOR DRUG | 2022-03-03 |
20220062317 | NA+/K+ ATPASE INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF METASTASIS | 2022-03-03 |
20220062318 | HEAT STRESS RELIEVING AGENT | 2022-03-03 |
20220062319 | COMBINATION IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIAL DISEASES | 2022-03-03 |
20220062320 | PREVENTING AND TREATING AMYLOID- BETA DEPOSITION BY STIMULATION OF INNATE IMMUNITY | 2022-03-03 |
20220062321 | METHODS FOR IMPROVING EXERCISE TOLERANCE IN MYALGIC ENCEPHALOMYELITIS PATIENTS | 2022-03-03 |
20220062322 | Dosage Form for Treating Severe Asthma | 2022-03-03 |
20220062323 | BIVALENT TARGETED CONJUGATES | 2022-03-03 |
20220062324 | BIOMATERIALS COMPRISING HYALURONIC ACID BINDING PEPTIDES AND EXTRACELLULAR MATRIX BINDING PEPTIDES FOR HYALURONIC ACID RETENTION AND TISSUE ENGINEERING APPLICATIONS | 2022-03-03 |
20220062325 | ENHANCING AAV-MEDIATED TRANSDUCTION OF OCULAR TISSUES WITH HYALURONIC ACID | 2022-03-03 |
20220062326 | USE OF MATERIALS MADE OF CROSS-LINKED BETA-CYCLODEXTRINS FOR THE TREATMENT OF TUBERCULOSIS | 2022-03-03 |
20220062327 | SKIN COMPOSITIONS AND METHODS OF USE THEREOF | 2022-03-03 |
20220062328 | COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS | 2022-03-03 |
20220062329 | METHOD OF ADMINISTRATION AND TREATMENT | 2022-03-03 |
20220062330 | USE OF THIOSULFATE TO POTENTIATE THE ANTI-PATHOGENIC EFFECT OF LACTOBACILLI | 2022-03-03 |
20220062331 | TREATING IRON DEFICIENCY IN SUBJECTS AT RISK OF CARDIOVASCULAR ADVERSE EVENTS AND IRON FOR THE MANAGEMENT OF ATRIAL FIBRILLATION | 2022-03-03 |
20220062332 | Method of Treatment for HIV Infection | 2022-03-03 |
20220062333 | Skin Care Formulation for the Treatment of Acne | 2022-03-03 |
20220062334 | COMPOSITIONS COMPRISING SILVER NITRATE, HYALURONIC ACID AND ALLANTOIN AND METHODS FOR USE THEREOF | 2022-03-03 |
20220062335 | ANTIMICROBIAL COMPOSITION WITH PROCOAGULANT, IMMUNOMODULATORY, AND TISSUE REGENERATIVE PROPERTIES | 2022-03-03 |
20220062336 | METHOD FOR ACCELERATING NERVE REGENERATION | 2022-03-03 |
20220062337 | TREATMENT AND DIAGNOSIS OF AUTOANTIBODY-MEDIATED EYE DISEASES | 2022-03-03 |
20220062338 | PSCA CAR-T CELLS | 2022-03-03 |
20220062339 | USE OF AN ANTI-CD45 ANTIBODY DRUG CONJUGATE (ADC) IN CELL THERAPY | 2022-03-03 |
20220062340 | IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS | 2022-03-03 |
20220062341 | MODIFIED TCR AND PRODUCTION METHOD THEREFOR | 2022-03-03 |
20220062342 | IMPROVED TARGETED T-CELL THERAPY FOR TREATMENT OF MULTIPLE MYELOMA | 2022-03-03 |
20220062343 | GENETICALLY MODIFIED NK-92 CELLS HAVING A SAFETY SWITCH | 2022-03-03 |
20220062344 | COMPOSITIONS AND METHODS FOR PROVIDING HEALTH BENEFITS IN AN ANIMAL | 2022-03-03 |
20220062345 | PHARMACEUTICAL COMPOSITION CONTAINING PROTEIN KINASE C ACTIVATOR-TREATED STEM CELLS OR CULTURE THEREOF FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES | 2022-03-03 |
20220062346 | USE OF miRNA IN PREPARATION OF A DRUG FOR PREVENTING AND TREATING OSTEOARTHRITIS, AN EXOSOME HIGHLY EXPRESSING miRNA AND USE THEREOF | 2022-03-03 |
20220062347 | INDUCTION METHOD FOR MACROPHAGE, ANTI-INFLAMMATORY MACROPHAGE-INDUCING AGENT, AND PHARMACEUTICAL COMPOSITION | 2022-03-03 |
20220062348 | ISOLATED SEPTAL CARTILAGE EXOSOME USED FOR GENERATING CARTILAGE TISSUE | 2022-03-03 |
20220062349 | DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND TISSUES | 2022-03-03 |
20220062350 | OIL-IN-WATER EMULSION GUMMY COMPOSITION | 2022-03-03 |
20220062351 | USE OF HEMOLYMPH OR HEMOLYMPH COMPONENTS TO REGENERATE, REPAIR AND RESTORE THE SKIN BARRIER | 2022-03-03 |
20220062352 | COMPOSITIONS FOR THE TREATMENT OF CONDITIONS | 2022-03-03 |
20220062353 | NANO-VESICLES DERIVED FROM GENUS SPHINGOMONAS BACTERIA AND USE THEREOF | 2022-03-03 |
20220062354 | TOPICAL FORMULATIONS FOR THE DELIVERY OF MICROBIALLY DERIVED MATERIALS | 2022-03-03 |
20220062355 | PHARMACEUTICAL COMPOSITION COMPRISING LACTOBACILLUS SAKEI WIKIM30 AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 2022-03-03 |
20220062356 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING INCONTINENCE, OVERACTIVE BLADDER, OR MENSTRUAL CRAMPING | 2022-03-03 |
20220062357 | METHOD AND COMPOSITION AGAINST VIRUS INFECTIONS WITH ACTIVATED INNATE LYMPHOID CELLS (ILCS) | 2022-03-03 |
20220062358 | Method for the Stimulation of Human Immune Cells | 2022-03-03 |
20220062359 | STRAIN OF SACCHAROMYCES CEREVISIAE VAR. BOULARDII FOR TREATING INFECTIOUS DISEASES OF THE ORAL CAVITY | 2022-03-03 |
20220062360 | CANNABINOID COMPOSITION AND METHOD OF SUBLINGUAL, BUCCAL AND ORAL MUCOSA DELIVERY | 2022-03-03 |
20220062361 | Herbal Supplement Composition and Method for Improved Digestion of Food | 2022-03-03 |
20220062362 | Composition for Increasing Occupancy of Faecalibacterium in Intestinal Flora | 2022-03-03 |
20220062363 | METHOD FOR TREATING GLIOBLASTOMA MULTIFORME | 2022-03-03 |
20220062364 | METHOD FOR TREATING A SIDE EFFECT CAUSED BY BCG PERFUSION THERAPY FOR BLADDER CANCER | 2022-03-03 |
20220062365 | METHOD AND COMPOSITIONS FOR THE USE OF BOTANICAL EXTRACTS IN THE TREATMENT OF VIRAL INFECTIONS | 2022-03-03 |
20220062366 | FEIJOA FRUIT EXTRACT | 2022-03-03 |
20220062367 | Upregulation of Therapeutic T Regulatory Cells and Suppression of Suicidal Ideations in Response to Inflammation by Administration of Nutraceutical Compositions Alone or Combined with Minocycline | 2022-03-03 |
20220062368 | Weight Management Composition | 2022-03-03 |
20220062369 | EDIBLE BLENDED VEGETABLE OIL FOR REDUCING BLOOD LIPIDS AND CHOLESTEROL | 2022-03-03 |
20220062370 | Methods and Compositions for Maintaining the Conformation and Structural Integrity of Biomolecules | 2022-03-03 |
20220062371 | LIGAND-DRUG-CONJUGATES AS SUBSTRATES FOR SELECTIVE CLEAVAGE BY THE EXOPEPTIDASE ACTIVITY OF CATHEPSIN B | 2022-03-03 |
20220062372 | METHODS FOR TREATING DISEASE AND REDUCING DRUG-INDUCED LIVER INJURY IN PATIENT POPULATIONS | 2022-03-03 |
20220062373 | Methods for Modulating Macrophage Activity | 2022-03-03 |
20220062374 | COMPOSITIONS COMPRISING CYCLOSPORIN | 2022-03-03 |
20220062375 | Compositions and Methods for Dengue Virus Chimeric Constructions in Vaccines | 2022-03-03 |
20220062376 | MOLECULAR SIGNATURE OF CANCER | 2022-03-03 |
20220062377 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES | 2022-03-03 |
20220062378 | METHODS OF TREATING OR INHIBITING ONSET OF HUNTINGTON'S DISEASE | 2022-03-03 |
20220062379 | METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION | 2022-03-03 |
20220062381 | METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH | 2022-03-03 |
20220062382 | METHODS OF DOWNREGULATING CCL20 GENES FOR TREATMENT OF TRAUMATIC BRAIN INJURIES | 2022-03-03 |
20220062383 | REGULATION OF A FOREIGN BODY RESPONSE | 2022-03-03 |
20220062384 | MANUFACTURE, FORMULATION AND DOSING OF APRAGLUTIDE | 2022-03-03 |
20220062385 | Method of Treating Hepatic Steatosis | 2022-03-03 |
20220062386 | Methods for Imaging and Treatment of Somatostatin-Receptor Positive Tumors | 2022-03-03 |
20220062387 | TARGETING OF MELANOCYTES FOR DELIVERING THERAPEUTIC OR DIAGNOSTIC AGENTS USING PROTEIN NANOCAGES | 2022-03-03 |
20220062388 | COMPOSITIONS, USES AND METHODS FOR TREATMENT OF INFERTILITY AND SUBFERTILITY | 2022-03-03 |
20220062389 | METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES USING FNDC5 | 2022-03-03 |
20220062390 | METHODS OF TREATING CANCER | 2022-03-03 |
20220062391 | ENHANCING EPITHELIAL OR ENDOTHELIAL BARRIER FUNCTION | 2022-03-03 |
20220062392 | COLLECTING PHYSICAL THERAPY INFORMATION TO ENHANCE TREATMENT EFFICACY OF BOTULINUM TOXIN | 2022-03-03 |
20220062393 | METHODS AND MATERIALS FOR REDUCING CARDIAC XENOGRAFT REJECTION | 2022-03-03 |
20220062394 | METHODS FOR IDENTIFYING NEOANTIGENS | 2022-03-03 |
20220062395 | IMMUNOTHERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | 2022-03-03 |
20220062396 | HUMAN APPLICATION OF ENGINEERED CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS | 2022-03-03 |
20220062397 | Vaccines targeting neoepitopes | 2022-03-03 |
20220062398 | LONG CHAIN ANTIGEN CONTAINING INTEREPITOPE SEQUENCE THAT PROMOTES ANTIGEN PRESENTATION TO T CELLS | 2022-03-03 |
20220062399 | IL-15-BASED FUSIONS TO IL-12 AND IL-18 | 2022-03-03 |
20220062400 | Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect | 2022-03-03 |
20220062401 | VACCINE COMPOSITIONS FOR CLOSTRIDIUM DIFFICILE | 2022-03-03 |
20220062402 | COMPOSITIONS, METHODS AND USES FOR ELICITING AN IMMUNE RESPONSE | 2022-03-03 |
20220062403 | ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED | 2022-03-03 |
20220062404 | GP38-TARGETING MONOCLONAL ANTIBODIES PROTECT ADULT MICE AGAINST LETHAL CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS INFECTION | 2022-03-03 |
20220062405 | UNGULATE-DERIVED POLYCLONAL IMMUNOGLOBULIN SPECIFIC FOR CORONAVIRUS PROTEIN AND USES THEREOF | 2022-03-03 |
20220062406 | IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF | 2022-03-03 |
20220062407 | BOVINE HERPESVIRUS TYPE 1 (BOHV-1) VECTOR AGAINST BOVINE RESPIRATORY DISEASE COMPLEX | 2022-03-03 |